The IMPACT (International Middle East Personalized AntiCancer Therapy) Conference is an annual Merck Middle East event which aims to support exchange of best practice and topical discussion. This year’s meeting will cover the latest insights into the treatment and management of mCRC and SCCHN with the spotlight on the patient, with aglobal panel of 10 experts and 100 attendees from around the world.
IMPACT III
